NPI: 1306814066 · CITRA, FL 32113 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,854 | $876K |
| 2019 | 7,399 | $1.62M |
| 2020 | 11,577 | $1.94M |
| 2021 | 2,738 | $583K |
| 2022 | 1,409 | $206K |
| 2023 | 490 | $89K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 11,073 | 820 | $2.26M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,729 | 342 | $1.55M |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,425 | 232 | $616K |
| A4657 | Syringe, with or without needle, each | 1,027 | 506 | $297K |
| J1756 | Injection, iron sucrose, 1 mg | 1,275 | 264 | $213K |
| 85048 | 466 | 341 | $87K | |
| 85041 | 469 | 344 | $87K | |
| 82728 | 248 | 171 | $52K | |
| 83550 | 243 | 168 | $51K | |
| 83540 | 243 | 168 | $51K | |
| 83970 | 168 | 124 | $27K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 20 | 13 | $5K |
| 82746 | 16 | 13 | $5K | |
| 82607 | 17 | 14 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 16 | 12 | $3K |
| G0008 | Administration of influenza virus vaccine | 16 | 12 | $893.98 |
| 90674 | 16 | 12 | $893.98 |